Drug intelligence / Profile preview

carboxymethylcellulose + glycerine

Development stage
Phase 4
Lead developer
Ajanta Pharma
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Carboxymethylcellulose + glycerine is a combination ophthalmic preparation used primarily for the symptomatic relief of dry eye disease. Carboxymethylcellulose acts as a lubricant and increases tear viscosity, mimicking natural tears to maintain ocular surface moisture and protect against further irritation. Glycerine functions as an ophthalmic demulcent, forming a soothing film over the mucous membrane surfaces of the eye to provide additional lubrication and comfort. Together, these agents temporarily relieve burning, irritation, and discomfort associated with dry eyes due to insufficient or poor-quality tear production[3][7]. The combination does not treat underlying causes but alleviates symptoms by stabilizing the tear film and reducing evaporation.

Brand names
SoftdropsJust TearsAqualubeOsmodropsLoc TearsZonasoftNeutear SoftTrotearCarmilonEhalub
Other names
carboxymethylcellulose + glycerin
02

Targets

GLUT1 (Glucose transporter 1)

Beyond the preview

Go deeper on carboxymethylcellulose + glycerine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carboxymethylcellulose + glycerine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call